Ever Better Labs Logo

Ever Better Labs – Peptide Selector

Explore high-level, non-personalized ranges for common peptides. Select a category and goal to see which peptides often show up in that conversation.

Disclaimer: Peptides, GLP-1 agents, GH secretagogues, and related compounds may be prescription-only, off-label, or research-only depending on jurisdiction. Ranges shown are approximate and generalized, pulled from publicly available literature and online sources. Always defer to a licensed clinician and local law. Do not self-diagnose, self-inject, or modify prescribed treatment based on this chart.
Filter Your Peptide View
Choose a high-level category (mechanism) and a goal (what you're optimizing for).

Semaglutide

Metabolic / GLP-1
πŸ’‰SubQ

Commonly used for type 2 diabetes management and medically supervised weight loss.

Typical: 0.25–2.4 mg once weekly (titrated).

Frequency: Weekly, step-wise escalation under supervision.

Tirzepatide

Metabolic / GLP-1 & GIP
πŸ’‰SubQ

Used for blood sugar control and significant weight reduction in people with obesity or diabetes.

Typical: 2.5–15 mg once weekly (stepwise titration).

Frequency: Weekly, titrated up over time.

Tesamorelin

GH Secretagogue
πŸ’‰SubQ

Approved for reducing excess visceral fat in HIV-associated lipodystrophy; explored for GH-axis support.

Typical: 1–2 mg once daily.

Frequency: Daily (SubQ), often at night.

Sermorelin

GH Secretagogue
πŸ’‰SubQ

Compounded GH-releasing hormone analog used to support growth hormone secretion in adults.

Typical: 100–500 mcg nightly.

Frequency: Once daily, usually at night.

Ipamorelin

GH Secretagogue
πŸ’‰SubQ

Often combined with GHRH analogs to promote pulsatile GH release for body composition and recovery goals.

Typical: 100–300 mcg 1–3Γ— daily.

Frequency: 1–3 times per day.

CJC-1295 (no DAC)

GHRH Analog
πŸ’‰SubQ

Short-acting GHRH analog used in compounding to support GH/IGF-1 axis in a pulsatile fashion.

Typical: 100–300 mcg 1–3Γ— daily.

Frequency: 1–3 times per day.

CJC-1295 (DAC)

Long-Acting GHRH
πŸ’‰SubQ

Long-acting GH-releasing hormone analog explored for sustained increases in GH and IGF-1.

Typical: 1–2 mg once weekly.

Frequency: Weekly or every 2 weeks.

BPC-157

Tissue Repair / GI
πŸ’‰SubQ πŸ’ŠOral

Research peptide discussed for tendon, ligament, joint, and GI tract support in experimental models.

Typical: 250–500 mcg 1–2Γ— daily.

Frequency: Once or twice daily.

TB-500 (Thymosin Ξ²4 fragment)

Tissue Repair
πŸ’‰SubQ

Thymosin Ξ²4–derived peptide studied for wound healing, tissue repair, and recovery in animals.

Typical: 2–10 mg per week, often divided.

Frequency: 1–3 injections per week in cycles.

Thymosin Alpha-1

Immune Modulation
πŸ’‰SubQ

Immunomodulatory peptide used in some countries for chronic viral infections and immune support.

Typical: 0.8–1.6 mg 2–3Γ— weekly.

Frequency: 2–3 times per week.

GHK-Cu

Skin / Hair
🧴Topical πŸ’‰SubQ (research)

Copper tripeptide complex used in topical cosmeceuticals for skin rejuvenation and hair support.

Typical: Topical 0.05–2% Β· microgram injections 1–3Γ— weekly.

Frequency: Daily (topical) or weekly (injection), protocol-dependent.

Epithalon (Epitalon)

Telomere / Experimental
πŸ’‰IM/SubQ (research)

Pineal-derived tetrapeptide studied in Russia for sleep, aging biomarkers, and telomere effects.

Typical: 5–10 mg daily in short cycles.

Frequency: Daily during 10–20 day courses in older studies.

Semax

Nootropic / Neuro
🌬️Intranasal

ACTH-derived peptide developed in Russia and explored for cognition, focus, and neuroprotection.

Typical: 200–600 mcg per day intranasal.

Frequency: Multiple divided doses per day.

Selank

Anxiolytic / Nootropic
🌬️Intranasal πŸ’‰SubQ

Heptapeptide analog of tuftsin researched for anxiolytic, stress-modulating, and cognitive effects.

Typical: 200–600 mcg per day intranasal.

Frequency: Divided doses throughout the day.

Cerebrolysin

Neurotrophic Mix
πŸ’§IV

Porcine brain–derived peptide mixture studied for stroke, dementia, and traumatic brain injury.

Typical: 5–30 mL IV once daily in cycles.

Frequency: Daily during 10–20 day cycles (where approved).

Dihexa

Experimental Nootropic
πŸ’ŠOral 🧴Transdermal

Angiotensin-derived small molecule investigated preclinically for synaptogenesis and memory.

Typical: Microgram–low milligram daily ranges.

Frequency: Once daily (experimental).

NAD⁺ (IV)

Redox / Metabolic
πŸ’§IV

Oxidized coenzyme used in IV wellness and addiction clinics for cellular energy and detox support.

Typical: 250–1,000 mg per infusion.

Frequency: Intermittent sessions (e.g., weekly or monthly per protocol).

NR / NMN

NAD⁺ Precursors
πŸ’ŠOral

Oral precursors to NAD⁺ marketed as supplements for cellular energy and healthy aging support.

Typical: 250–1,000 mg per day orally.

Frequency: Once or twice daily.

MOTS-c

Mitochondrial Peptide
πŸ’‰SubQ

Mitochondria-encoded peptide studied for exercise-like metabolic effects and insulin sensitivity.

Typical: 5–15 mg per week.

Frequency: 2–3 injections per week (experimental).

KPV

Anti-Inflammatory / Immune
πŸ’ŠOral πŸ’‰SubQ 🧴Topical

Ξ±-MSH–derived tripeptide explored for inflammatory bowel issues, skin inflammation, and gut barrier support.

Typical: 250–1,000 mcg per day.

Frequency: Once or multiple times daily, route-dependent.

Melanotan II

Tanning / Libido
πŸ’‰SubQ

Synthetic melanocortin analog used off-label for tanning and libido enhancement; carries safety concerns.

Typical: 250–1,000 mcg per injection during loading.

Frequency: Several injections per week initially, then maintenance (anecdotal).

PT-141 (Bremelanotide)

Sexual Health
πŸ’‰SubQ

FDA-approved in some regions for hypoactive sexual desire disorder in premenopausal women.

Typical: 1.25–1.75 mg as needed.

Frequency: On-demand, not daily, per label / protocol.

AOD-9604

GH Fragment / Fat Metabolism
πŸ’‰SubQ πŸ’ŠOral lozenge

Fragment of human growth hormone investigated for lipolysis and weight management applications.

Typical: 250–600 mcg once daily.

Frequency: Daily.

IGF-1 LR3

IGF Analog – Banned in Sport
πŸ’‰SubQ/IM (research)

Long-acting IGF-1 analog studied experimentally for muscle growth but prohibited in competitive sports.

Typical: 20–100 mcg per injection.

Frequency: Often once daily or post-workout in experimental contexts.

Follistatin (344/315)

Myostatin Axis / Experimental
πŸ’‰IM/SubQ (research)

Myostatin-binding protein fragments explored for muscle mass enhancement in early research.

Typical: Multi-mg short-course protocols.

Frequency: Daily or every other day during brief cycles (experimental).

GHRP-2

GH Secretagogue
πŸ’‰SubQ

Ghrelin mimetic explored for GH pulse stimulation, appetite, and body composition changes.

Typical: 100–300 mcg 1–3Γ— daily.

Frequency: 1–3 times per day.

GHRP-6

GH Secretagogue
πŸ’‰SubQ

Ghrelin receptor agonist with pronounced appetite stimulation, used experimentally for GH release.

Typical: 100–300 mcg 1–3Γ— daily.

Frequency: 1–3 times per day (notable appetite stimulation).

Hexarelin

GH Secretagogue
πŸ’‰SubQ

Potent GH secretagogue researched for anabolic effects and sometimes for cardiac applications.

Typical: 100–200 mcg 1–2Γ— daily in short courses.

Frequency: Once or twice daily, limited-duration cycles.

LL-37

Antimicrobial / Immune
πŸ’‰SubQ 🧴Topical

Human cathelicidin fragment studied for antimicrobial activity and immune modulation.

Typical: Low milligram weekly totals.

Frequency: A few injections per week in experimental protocols.

Thymulin / Thymic Peptides

Thymic / Immune Support
πŸ’‰IM/SubQ

Historic thymic extracts and synthetic analogs studied for supporting T-cell maturation and immune balance.

Typical: Microgram-to-milligram doses in older studies.

Frequency: Varies by preparation and protocol.

β€œWolverine”-Style Blends

Combo: BPC-157 + TB-500 Β± GHK
πŸ’‰SubQ

Compounded injury-repair blends combining multiple tissue-support peptides into one vial.

Typical: Total weekly dose mirrors BPC + TB-500 ranges, split by ratio.

Frequency: Multiple injections per week per compounder / protocol.

Kisspeptin (KISS-1)

Reproductive Axis / Research
πŸ’§IV πŸ’‰SubQ

Hypothalamic peptide studied in fertility and reproductive endocrinology for GnRH/LH/FSH modulation.

Typical: Microgram-to-milligram doses in fertility / IVF research.

Frequency: Single or repeated doses depending on study design.